Old Web
English
Sign In
Acemap
>
authorDetail
>
Stefanie R. Mullins
Stefanie R. Mullins
AstraZeneca
Tumor microenvironment
Immune system
Immunotherapy
Cancer research
Innate immune system
2
Papers
61
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Intratumoral administration of the Toll-like receptor 7/8 agonist 3M-052 enhances interferon-driven tumor immunogenicity and suppresses metastatic spread in preclinical triple-negative breast cancer.
2020
Clinical And Translational Immunology
Damien Zanker
Alex J Spurling
Natasha K. Brockwell
Katie L. Owen
Jasmine M. Zakhour
Tina Robinson
Hendrika M. Duivenvoorden
Paul J. Hertzog
Stefanie R. Mullins
Robert W. Wilkinson
Belinda S. Parker
Show All
Source
Cite
Save
Citations (9)
Intratumoral immunotherapy with TLR7/8 agonist MEDI9197 modulates the tumor microenvironment leading to enhanced activity when combined with other immunotherapies
2019
Journal for ImmunoTherapy of Cancer
Stefanie R. Mullins
John P. Vasilakos
Katharina Deschler
Iwen Grigsby
Pete Gillis
Julius John
Matthew J. Elder
John G. Swales
Elina Timosenko
Zachary Cooper
Simon J. Dovedi
Andrew J. Leishman
Nadia Luheshi
James Elvecrog
Ashenafi Tilahun
Richard J. A. Goodwin
Ronald Herbst
Mark A. Tomai
Robert W. Wilkinson
Show All
Source
Cite
Save
Citations (52)
1